An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Journal: Science Translational Medicine

Published: 2020-04-29

DOI: 10.1126/scitranslmed.abb5883

Affiliations: 10

Authors: 28

Go to article
Institutions Share
Department of Pediatrics, VU, United States of America (USA) 0.29
UNC Department of Epidemiology, United States of America (USA) 0.25
Emory Institute for Drug Development (EIDD), Emory University, United States of America (USA) 0.12
Centers for Disease Control and Prevention (CDC), United States of America (USA) 0.11
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.09
Drug Innovation Ventures at Emory, LLC (DRIVE), United States of America (USA) 0.05
UNC Department of Microbiology and Immunology, United States of America (USA) 0.04
UNC Department of Pathology and Laboratory Medicine, United States of America (USA) 0.04
UNC Department of Biochemistry and Biophysics, United States of America (USA) 0.02
Department of Pharmacology and Chemical Biology, Emory University, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER